HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Appelbaum, F. R. Search for Related Content PubMed PubMed Citation Articles by Appelbaum, F. R.

CA: A Cancer Journal for Clinicians, Vol 46, Issue 3 142-164, Copyright © 1996 by American Cancer Society

ARTICLES

The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer

F. R. Appelbaum
University of Washington, Seattle, USA.

Since its first successful application 25 years ago, the clinical use of bone marrow and peripheral blood stem cell transplantation has increased dramatically. Transplantation allows for the administration of high doses of systematic chemotherapy and radiotherapy and confers an antitumor effect separate from the effects of chemotherapy. However,complications including toxicity of treatment, graft failure, and graft-versus-host disease exist. This article reviews the history and current use of bone marrow and peripheral blood stem cell transplantation and outlines new approaches for clinical application.

This article has been cited by other articles:

				F. R. Loberiza Jr, M.-J. Zhang, S. J. Lee, J. P. Klein, C. F. LeMaistre, D. S. Serna, M. Eapen, C. N. Bredeson, M. M. Horowitz, and J. D. Rizzo Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States Blood, April 1, 2005; 105(7): 2979 - 2987. [Abstract] [Full Text] [PDF]

				D. S. Serna, S. J. Lee, M.-j. Zhang, K. S. Baker, M. Eapen, M. M. Horowitz, J. P. Klein, J. D. Rizzo, and F. R. Loberiza Jr Trends in Survival Rates After Allogeneic Hematopoietic Stem-Cell Transplantation for Acute and Chronic Leukemia by Ethnicity in the United States and Canada J. Clin. Oncol., October 15, 2003; 21(20): 3754 - 3760. [Abstract] [Full Text] [PDF]

				H G. Welch and J. Mogielnicki Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer BMJ, May 4, 2002; 324(7345): 1088 - 1092. [Full Text] [PDF]

				P. Schwarzenberger, W. Huang, P. Oliver, P. Byrne, V. La Russa, Z. Zhang, and J. K. Kolls IL-17 Mobilizes Peripheral Blood Stem Cells with Short- and Long-Term Repopulating Ability in Mice J. Immunol., August 15, 2001; 167(4): 2081 - 2086. [Abstract] [Full Text] [PDF]

				E.C. LaCasse, M.R. Bray, B. Patterson, W.-M. Lim, S. Perampalam, L. G. Radvanyi, A. Keating, A.K. Stewart, R. Buckstein, J.S. Sandhu, et al. Shiga-Like Toxin-1 Receptor on Human Breast Cancer, Lymphoma, and Myeloma and Absence From CD34+ Hematopoietic Stem Cells: Implications for Ex Vivo Tumor Purging and Autologous Stem Cell Transplantation Blood, October 15, 1999; 94(8): 2901 - 2910. [Abstract] [Full Text] [PDF]

				J. D. Rizzo, G. B. Vogelsang, S. Krumm, B. Frink, V. Mock, and E. B. Bass Outpatient-Based Bone Marrow Transplantation for Hematologic Malignancies: Cost Saving or Cost Shifting? J. Clin. Oncol., September 1, 1999; 17(9): 2811 - 2811. [Abstract] [Full Text] [PDF]